Banca Mediolanum SpA (IT:BMED)
:BMED
Want to see IT:BMED full AI Analyst Report?
BMED Stock Chart & Stats
€19.61
€0.41(3.50%)
At close: 4:00 PM EST
€19.61
€0.41(3.50%)
Day’s Range― - ―
52-Week Range€12.91 - €20.68
Previous CloseN/A
Volume2.91M
Average Volume (3M)1.19M
Market Cap
€13.73B
Enterprise Value€16.69B
Total Cash (Recent Filing)€806.77M
Total Debt (Recent Filing)€393.24M
Price to Earnings (P/E)11.6
Beta1.10
Next Earnings
May 07, 2026EPS Estimate
0.34Next Dividend Ex-DateN/A
Dividend Yield6.35%
Share Statistics
EPS (TTM)0.60
Shares Outstanding745,413,900
10 Day Avg. Volume1,292,738
30 Day Avg. Volume1,192,469
Financial Highlights & Ratios
PEG Ratio1.10
Price to Book (P/B)3.20
Price to Sales (P/S)2.82
P/FCF Ratio2.82
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€21.83Price Target Upside11.30% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)1.41
Revenue Forecast (FY)€2.35B
Bulls Say, Bears Say
Bulls Say
High Profitability & ROESustained high profitability and a near-30% ROE reflect strong earnings power and efficient capital use. Durable margin levels and recurring fee mix provide a structural buffer versus cyclicality, supporting dividend policy and reinvestment capacity over the next 2–6 months.
Advisor-led Distribution And Strong InflowsA large, growing advisor network plus industry-leading assets per banker create durable competitive advantage in client acquisition and cross‑selling. Consistent net inflows into managed assets underpin recurring fee revenue and scalability of wealth margins over the medium term.
Strong Capital And Cash GenerationRobust capital (CET1 ~23%) and materially improved operating/free cash flow enhance financial flexibility. This supports planned lending expansion, dividend increases and buffers against stress, making strategic execution and capital returns more durable over coming quarters.
Bears Say
Revenue And Cash-flow VolatilityHistoric swings in revenue and cash generation reduce predictability of earnings and complicate capital planning. For a fee‑and‑NII reliant model, this volatility can force cyclical provisioning or earnings variability, limiting the reliability of cash returns over the next 2–6 months.
Dependence On Market-sensitive Fees And CertificatesSignificant reliance on performance fees and upfront certificate revenues creates structurally variable fee income. Market swings, fund watermarks and early redemptions can materially reduce fees quarter-to-quarter, making revenue streams less stable during adverse market conditions.
Spain Margin Compression At Current ScaleRapid volume growth in Spain has not yet delivered proportional profit margins; lower NII and higher costs compress returns at current scale. Continued investment is needed to reach break‑even margins, posing execution and return‑on‑capital risk during the scaling phase.
Banca Mediolanum SpA News
BMED FAQ
What was Banca Mediolanum SpA’s price range in the past 12 months?
Banca Mediolanum SpA lowest stock price was €12.91 and its highest was €20.68 in the past 12 months.
What is Banca Mediolanum SpA’s market cap?
Banca Mediolanum SpA’s market cap is €13.73B.
When is Banca Mediolanum SpA’s upcoming earnings report date?
Banca Mediolanum SpA’s upcoming earnings report date is May 07, 2026 which is in 7 days.
How were Banca Mediolanum SpA’s earnings last quarter?
Banca Mediolanum SpA released its earnings results on Feb 03, 2026. The company reported €0.596 earnings per share for the quarter, beating the consensus estimate of €0.486 by €0.11.
Is Banca Mediolanum SpA overvalued?
According to Wall Street analysts Banca Mediolanum SpA’s price is currently Undervalued.
Does Banca Mediolanum SpA pay dividends?
Banca Mediolanum SpA pays a Semiannually dividend of €0.6 which represents an annual dividend yield of 6.35%. See more information on Banca Mediolanum SpA dividends here
What is Banca Mediolanum SpA’s EPS estimate?
Banca Mediolanum SpA’s EPS estimate is 0.34.
How many shares outstanding does Banca Mediolanum SpA have?
Banca Mediolanum SpA has 745,413,900 shares outstanding.
What happened to Banca Mediolanum SpA’s price movement after its last earnings report?
Banca Mediolanum SpA reported an EPS of €0.596 in its last earnings report, beating expectations of €0.486. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Banca Mediolanum SpA?
Currently, no hedge funds are holding shares in IT:BMED
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Banca Mediolanum SpA
Banca Mediolanum S.p.A. provides various banking products and services in Italy. The company offers current accounts and mortgages and loans. It also provides debit, credit, and prepaid cards; savings and investment products, such as equities and bonds, as well as trading services; and insurance and pension products and services. The company was founded in 1982 and is headquartered in Basiglio, Italy.
BMED Company Deck
BMED Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a strongly positive operational and financial performance: record net income, robust fee growth, exceptional net inflows (particularly into managed assets), strong capital metrics (CET1 23%) and a meaningful dividend increase. The bank highlights durable, relationship-driven revenue growth and execution on strategic initiatives (NEXT, Grandi Patrimoni, Spain expansion). Key challenges include performance-fee volatility, higher provisions (including build-up for Prexta), sensitivity of certain fees to market conditions (certificates), and Spain's margin compression at current scale. Management provided constructive 2026 guidance (managed inflows ~EUR 9 billion, NII +~10%, cost-to-income ~38%, cost of risk ~20 bps) but acknowledged outcomes depend on market and rate assumptions. Overall, strengths and growth prospects materially outweigh the risks flagged, though execution and market conditions remain important to hit guidance.View all IT:BMED earnings summariesBMED Stock 12 Month Forecast
Average Price Target
€21.83
▲(11.30% Upside)
Technical Analysis
Banca Generali SpA
―
Banco BPM S.p.A.
―
FinecoBank SpA
―
Intesa Sanpaolo SpA
―
Mediobanca Banca di Credito Finanziario S.p.A.
―
Options Prices
Currently, No data available
---